Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CXCR7 antagonist-1 hydrochloride

😃Good
Catalog No. T62325Cas No. 2990472-61-0

CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits binding of SDF-1 chemokine (CXCL12 chemokine) or I-TAC to CXCR7, applicable for tumor and inflammation research.

CXCR7 antagonist-1 hydrochloride

CXCR7 antagonist-1 hydrochloride

😃Good
Purity: 99.84%
Catalog No. T62325Cas No. 2990472-61-0
CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits binding of SDF-1 chemokine (CXCL12 chemokine) or I-TAC to CXCR7, applicable for tumor and inflammation research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$189-In Stock
5 mg$479-In Stock
10 mg$793-In Stock
25 mg$1,570-In Stock
50 mg$2,650-In Stock
1 mL x 10 mM (in DMSO)$528-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.84%
Appearance:Solid
Color:Gray
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits binding of SDF-1 chemokine (CXCL12 chemokine) or I-TAC to CXCR7, applicable for tumor and inflammation research.
In vitro
CXCR7 antagonist-1 hydrochloride (10 μM; 48 h) restored β2-adrenergic receptor (β2AR) downregulation and muscle relaxation in infant airway smooth muscle cells induced by CXCL11 or RSV infection [2].
In vivo
CXCR7 antagonist-1 hydrochloride (10 μM; intranasal instillation; once daily; administered twice) suppressed RSV infection-induced airway smooth muscle relaxation in a BALB/c mouse model [2].
Chemical Properties
Molecular Weight426.87
FormulaC21H20ClFN6O
Cas No.2990472-61-0
SmilesN(C(=O)C1=NN(C=C1)C2=CC=C(F)C=C2)[C@@H]3CN(C=4C=5N(C=CN4)C=CC5)CC3.Cl
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 300 mg/mL (702.79 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3426 mL11.7132 mL23.4263 mL117.1317 mL
5 mM0.4685 mL2.3426 mL4.6853 mL23.4263 mL
10 mM0.2343 mL1.1713 mL2.3426 mL11.7132 mL
20 mM0.1171 mL0.5857 mL1.1713 mL5.8566 mL
50 mM0.0469 mL0.2343 mL0.4685 mL2.3426 mL
100 mM0.0234 mL0.1171 mL0.2343 mL1.1713 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy CXCR7 antagonist-1 hydrochloride | purchase CXCR7 antagonist-1 hydrochloride | CXCR7 antagonist-1 hydrochloride cost | order CXCR7 antagonist-1 hydrochloride | CXCR7 antagonist-1 hydrochloride chemical structure | CXCR7 antagonist-1 hydrochloride in vivo | CXCR7 antagonist-1 hydrochloride in vitro | CXCR7 antagonist-1 hydrochloride formula | CXCR7 antagonist-1 hydrochloride molecular weight